Terns Pharmaceuticals, Inc. financial data

Symbol
TERN on Nasdaq
Industry
Pharmaceutical Preparations
Location
1065 East Hillsdale Blvd., Suite 100, Foster City, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.6K % +6.48%
Debt-to-equity 4.57 % -4.39%
Return On Equity -32.8 % -5.71%
Return On Assets -31.3 % -5.92%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 84.9M shares +37.5%
Common Stock, Shares, Outstanding 84.9M shares +37.4%
Entity Public Float 409M USD +774%
Common Stock, Value, Issued 8K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 77.8M shares +8.79%
Weighted Average Number of Shares Outstanding, Diluted 77.8M shares +8.79%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 30.4M USD -21.3%
Costs and Expenses 100M USD +4.88%
Operating Income (Loss) -100M USD -4.88%
Nonoperating Income (Expense) 12.2M USD +12.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -87.8M USD -3.9%
Income Tax Expense (Benefit) 269K USD -47%
Net Income (Loss) Attributable to Parent -88.1M USD -3.6%
Earnings Per Share, Basic -1.18 USD/shares -6.31%
Earnings Per Share, Diluted -1.18 USD/shares -6.31%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 270M USD +613%
Marketable Securities, Current 103M USD -55.1%
Assets, Current 377M USD +39.2%
Property, Plant and Equipment, Net 295K USD -43.9%
Operating Lease, Right-of-Use Asset 1.38M USD +105%
Other Assets, Noncurrent 56K USD +60%
Assets 378M USD +39.2%
Accounts Payable, Current 1.79M USD -46.3%
Employee-related Liabilities, Current 4.28M USD +15.8%
Liabilities, Current 11.4M USD -5.59%
Accrued Income Taxes, Noncurrent 1.32M USD +18.5%
Operating Lease, Liability, Noncurrent 1.03M USD +1540%
Liabilities 13.8M USD +3.78%
Accumulated Other Comprehensive Income (Loss), Net of Tax 160K USD
Retained Earnings (Accumulated Deficit) -400M USD -28.3%
Stockholders' Equity Attributable to Parent 364M USD +41%
Liabilities and Equity 378M USD +39.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.8M USD -58.5%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 8M USD -71.4%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 84.9M shares +37.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.8M USD -136%
Deferred Tax Assets, Valuation Allowance 59.6M USD +41.3%
Deferred Tax Assets, Gross 182K USD -38.1%
Operating Lease, Liability 1.31M USD +69.5%
Payments to Acquire Property, Plant, and Equipment 29K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -87.1M USD -3.05%
Lessee, Operating Lease, Liability, to be Paid 1.55M USD +93.7%
Property, Plant and Equipment, Gross 2.12M USD -2.04%
Operating Lease, Liability, Current 272K USD -61.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 850K USD +27.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +66.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 241K USD +761%
Deferred Tax Assets, Operating Loss Carryforwards 19.9M USD +44%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 7.51M USD +18.8%
Additional Paid in Capital 764M USD +33.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 82K USD +7.9%
Share-based Payment Arrangement, Expense 15.9M USD -36.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%